DNA2.0 to Open UK Office for European Synthetic Gene Market | GenomeWeb
NEW YORK (GenomeWeb News) – California-based gene synthesis firm DNA2.0 is expanding by opening an arm in the UK called DNA2.0 Ltd., the company said today.
 
The company, which supplies synthetic genes to academic and government customers, as well as companies in the pharmaceutical, biotechnology, chemical, agricultural fields, already has a European office in Basel, Switzerland.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.